Literature DB >> 9714846

Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework.

P Jirholt1, M Ohlin, C A Borrebaeck, E Söderlind.   

Abstract

A novel approach in molecular design is presented, where in vivo formed complementarity determining regions (CDR) from antibody genes were shuffled into a specific framework region. A synthetic gene library of soluble VH-fragments was created and the complexity of the library was determined by sequencing. The synthetic genes were diverse and contained random combinations of CDR from different germlines. All CDR were randomised in one step and by using in vivo formed CDR, the length, sequence and combination were varied simultaneously.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714846     DOI: 10.1016/s0378-1119(98)00317-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.

Authors:  Takeshi Nakanishi; Kouhei Tsumoto; Akiko Yokota; Hidemasa Kondo; Izumi Kumagai
Journal:  Protein Sci       Date:  2008-02       Impact factor: 6.725

2.  Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling.

Authors:  Benjamin J Hackel; Atul Kapila; K Dane Wittrup
Journal:  J Mol Biol       Date:  2008-06-24       Impact factor: 5.469

3.  Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing.

Authors:  Javier Valdés-Alemán; Juan Téllez-Sosa; Marbella Ovilla-Muñoz; Elizabeth Godoy-Lozano; Daniel Velázquez-Ramírez; Humberto Valdovinos-Torres; Rosa E Gómez-Barreto; Jesús Martinez-Barnetche
Journal:  MAbs       Date:  2013-12-11       Impact factor: 5.857

4.  Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.

Authors:  Andreas Agathangelidis; Nikos Darzentas; Anastasia Hadzidimitriou; Xavier Brochet; Fiona Murray; Xiao-Jie Yan; Zadie Davis; Ellen J van Gastel-Mol; Cristina Tresoldi; Charles C Chu; Nicola Cahill; Veronique Giudicelli; Boris Tichy; Lone Bredo Pedersen; Letizia Foroni; Lisa Bonello; Agnieszka Janus; Karin Smedby; Achilles Anagnostopoulos; Helene Merle-Beral; Nikolaos Laoutaris; Gunnar Juliusson; Paola Francia di Celle; Sarka Pospisilova; Jesper Jurlander; Christian Geisler; Athanasios Tsaftaris; Marie-Paule Lefranc; Anton W Langerak; David Graham Oscier; Nicholas Chiorazzi; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Blood       Date:  2012-03-13       Impact factor: 22.113

Review 5.  Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains.

Authors:  Weizao Chen; Rui Gong; Tianlei Ying; Ponraj Prabakaran; Zhongyu Zhu; Yang Feng; Dimiter S Dimitrov
Journal:  Curr Drug Discov Technol       Date:  2014-03

6.  Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.

Authors:  Weizao Chen; Zhongyu Zhu; Yang Feng; Xiaodong Xiao; Dimiter S Dimitrov
Journal:  J Mol Biol       Date:  2008-07-26       Impact factor: 5.469

7.  Construction of a human antibody domain (VH) library.

Authors:  Weizao Chen; Zhongyu Zhu; Xiaodong Xiao; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2009

8.  A bispecific IgG format containing four independent antigen binding sites.

Authors:  Anne Ljungars; Torbjörn Schiött; Ulrika Mattson; Jessica Steppa; Björn Hambe; Monika Semmrich; Mats Ohlin; Ulla-Carin Tornberg; Mikael Mattsson
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

9.  Generation of a highly reactive chicken-derived single-chain variable fragment against Fusarium verticillioides by phage display.

Authors:  Zu-Quan Hu; Jin-Long Liu; He-Ping Li; Shu Xing; Sheng Xue; Jing-Bo Zhang; Jian-Hua Wang; Greta Nölke; Yu-Cai Liao
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

10.  Seeking high-priority mutations enabling successful antibody-breeding: systematic analysis of a mutant that gained over 100-fold enhanced affinity.

Authors:  Hiroyuki Oyama; Yuki Kiguchi; Izumi Morita; Chika Yamamoto; Yuka Higashi; Miku Taguchi; Tatsuya Tagawa; Yuri Enami; Yuriko Takamine; Hanako Hasegawa; Atsuko Takeuchi; Norihiro Kobayashi
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.